Cargando…

Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria

Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable presence of angioedema which persists for at least 6 weeks. It represents the most common subtype of chronic urticaria and is gaining importance in civil society because of its association with impaired quality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folci, Marco, Heffler, Enrico, Canonica, Giorgio W., Furlan, Raffaello, Brunetta, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280255/ https://www.ncbi.nlm.nih.gov/pubmed/30584542 http://dx.doi.org/10.1155/2018/5615109

Ejemplares similares

Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients
por: Brunetta, Enrico, et al.
Publicado: (2018)

Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome
por: Ramponi, Giacomo, et al.
Publicado: (2020)

Autoinflammatory manifestations in adult patients
por: Rodolfi, Stefano, et al.
Publicado: (2022)

Biologic drugs in chronic spontaneous urticaria
por: Licari, Amelia, et al.
Publicado: (2021)

Serum ANCA and Overall Mortality: A 10-Year Retrospective Cohort Study on 1,024 Italian Subjects
por: Brunetta, Enrico, et al.
Publicado: (2021)

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications
por: Puxeddu, Ilaria, et al.
Publicado: (2019)

Treatment of Chronic Spontaneous Urticaria
por: Kaplan, Allen P.
Publicado: (2012)

ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
por: Folci, Marco, et al.
Publicado: (2019)

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
por: Puxeddu, Ilaria, et al.
Publicado: (2017)

Immunological events in chronic spontaneous urticaria
por: Ferrer, Marta
Publicado: (2015)

Emerging Therapies in Chronic Spontaneous Urticaria
por: Min, Taek Ki, et al.
Publicado: (2019)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Biomarkers of disease activity in patients with chronic spontaneous urticaria
por: Plavsic, Aleksandra, et al.
Publicado: (2022)

The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations()
por: Sánchez-Borges, Mario, et al.
Publicado: (2021)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations
por: Kaplan, Allen P.
Publicado: (2017)

Immunological signature of chronic spontaneous urticaria (Review)
por: Dobrican, Carmen-Teodora, et al.
Publicado: (2022)

Biomarkers of Gut Microbiota in Chronic Spontaneous Urticaria and Symptomatic Dermographism
por: Liu, Runqiu, et al.
Publicado: (2021)

Autonomic Abnormalities in Patients With Primary Sjogren’s Syndrome – Preliminary Results
por: Brunetta, Enrico, et al.
Publicado: (2019)

Escaping the trap of allergic rhinitis
por: Rossi, Oliviero, et al.
Publicado: (2015)

Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
por: Sahiner, Umit M., et al.
Publicado: (2023)

Chronic recurrent wheals – If not chronic spontaneous urticaria, what else?
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

Chronic Spontaneous Urticaria: An Etiopathogenic Study
por: Maheshwari, Apoorva, et al.
Publicado: (2022)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Autoimmune Theories of Chronic Spontaneous Urticaria
por: Bracken, Sonali J., et al.
Publicado: (2019)

Definition of Recurrent Chronic Spontaneous Urticaria
por: MELÉ-NINOT, Gemma, et al.
Publicado: (2020)

Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success
por: Armstrong, April W., et al.
Publicado: (2023)

Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria
por: Bansal, Ciara Jade, et al.
Publicado: (2019)

Total IgE as a Marker for Chronic Spontaneous Urticaria
por: Altrichter, Sabine, et al.
Publicado: (2021)

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria
por: Diluvio, Laura, et al.
Publicado: (2020)

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs
por: Varricchi, Gilda, et al.
Publicado: (2016)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

Association of Gut Lachnospiraceae and Chronic Spontaneous Urticaria
por: Ćesić, Diana, et al.
Publicado: (2023)

Management of chronic spontaneous urticaria: a worldwide perspective
por: Kolkhir, Pavel, et al.
Publicado: (2018)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

EBASTINE IN CHRONIC SPONTANEOUS URTICARIA IN HIGHER DOSES
por: Godse, Kiran V
Publicado: (2011)

Fexofenadine in higher doses in chronic spontaneous urticaria
por: Godse, Kiran V., et al.
Publicado: (2010)

Oxidative Stress in Children with Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7d2k6521bmv9u9017acb46135c